Clin2
NCT07344506Possibly a fitRecruiting

Cure H. pylori: New combination therapy for stomach infection

H. Pylori Gastrointestinal DiseaseH.Pylori InfectionH.Pylori Eradication Rate

Part of Digestive system clinical trials.

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
942 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be an adult (18 years or older).
  • You must have been diagnosed with H. pylori infection using a breath test.
  • You cannot be currently taking any treatment for H. pylori.
  • You must not have taken any antibiotics in the last two weeks.
  • You must not be pregnant or breastfeeding.
  • You must not have any known allergies to the study medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012785Not yet recruiting
Brewer's yeast and minocycline for new H. pylori patients

This trial tests a treatment combining a probiotic (Saccharomyces boulardii) with an antibiotic (minocycline) for people who have never been treated for H. pylori infection. It aims to see if this combination works well and is safe.

Nanjing, Jiangsu
NCT07624422Not yet recruiting· Phase 4
Two antibiotic combinations for H. pylori stomach infection

This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.

Damascus
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07293910Recruiting· Phase 2
Comparing treatments for H. pylori infection

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Tanta
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT07729293Not yet recruiting
Pylori Duo for new H. pylori infection treatment

This trial tests a treatment called Pylori Duo for people newly diagnosed with H. pylori infection. It aims to both treat the infection and prevent it from coming back.

Don Benito, Badajoz

Hear when a new H. Pylori Gastrointestinal Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.